Pharmacy deserts are spreading across America. In one rural Arizona town, the only independent pharmacy is doing everything ...
Stocktwits on MSN
Hims & Hers CEO bets on personalized healthcare and AI in 2026 — Wall Street braces for a costly year
Dudum said individuals are taking greater control of care through DTC access, preventive health, and wider use of AI. ・BofA and Citi cut targets, citing margin pressure and a heavy investment outlook ...
The Wegovy pill is the first and only oral GLP-1 for weight loss in adults. The first and only oral GLP-1 for weight loss in adults is now available to consumers. Drugmaker Novo Nordisk announced ...
Novo Nordisk A/S is rated Buy with Wegovy pill seen as a potential catalyst to reignite growth & recapture market share. Read more on NVO stock here.
Novo Nordisk executive Dave Moore touted high interest in Wegovy's oral version of its injectable GLP-1 weight-loss ...
Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk announced Monday. Other strengths will be available as pills by the end of the ...
San Francisco-based Checkr has seen its revenues jump 14% to $800 million as companies try to spot a flood of AI-generated ...
The calendar flips from 2025 to 2026 this week and consumers needing to run errands, such as dropping off dry cleaning or filling a prescription, may want to plan ahead as there may be closures on and ...
Hims & Hers Health, Inc. faces short-term pressure after missing Novo’s partner list, but lab testing boosts long-term growth ...
The new Wegovy pill was just approved in the US—and it’s the first oral GLP-1 for weight management on the market. Trials suggest it’s approximately as effective as the injectable form, and it has ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Novo Nordisk plans to ...
LONDON, Dec 29 (Reuters) - Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: monthly GLP-1 medicine subscriptions like a streaming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results